Jonas Leu - Emmi AG Ex Management
| EMMN Stock | CHF 784.00 13.00 1.63% |
Insider
Jonas Leu is Ex Management of Emmi AG
| Age | 39 |
| Phone | 41 58 227 27 27 |
| Web | https://www.emmi.com |
Emmi AG Management Efficiency
The company has return on total asset (ROA) of 0.0663 % which means that it generated a profit of $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1663 %, meaning that it generated $0.1663 on every $100 dollars invested by stockholders. Emmi AG's management efficiency ratios could be used to measure how well Emmi AG manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Marc Schrader | Santhera Pharmaceuticals Holdin | N/A | |
| Astrid Schafer | Evolva Holding SA | 50 | |
| Ngo Nhan | COSMO Pharmaceuticals SA | 44 | |
| Gnther Metz | Santhera Pharmaceuticals Holdin | 65 | |
| Laurenz Kellenberger | Basilea Pharmaceutica AG | 56 | |
| Lutz Wevelsiep | Basilea Pharmaceutica AG | N/A | |
| David Veitch | Basilea Pharmaceutica AG | 58 | |
| Biagio Vigano | COSMO Pharmaceuticals SA | 49 | |
| Mauro Ajani | COSMO Pharmaceuticals SA | 68 | |
| Stefan Weber | Newron Pharmaceuticals SpA | 58 | |
| Luigi Longo | COSMO Pharmaceuticals SA | 44 | |
| Dietrich Stber | Basilea Pharmaceutica AG | N/A | |
| FCMA CGMA | Santhera Pharmaceuticals Holdin | 60 | |
| Alessandro LLM | COSMO Pharmaceuticals SA | 60 | |
| Ursula Eberhardt | Basilea Pharmaceutica AG | 61 | |
| Kaspar Mueller | Evolva Holding SA | 60 | |
| Davide Malavasi | COSMO Pharmaceuticals SA | 50 | |
| Marc MD | Basilea Pharmaceutica AG | 59 | |
| Oliver Strub | Santhera Pharmaceuticals Holdin | 60 | |
| Damian Heller | Basilea Pharmaceutica AG | 57 | |
| Hazel Winchester | COSMO Pharmaceuticals SA | 52 | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0663 |
Emmi AG Leadership Team
Elected by the shareholders, the Emmi AG's board of directors comprises two types of representatives: Emmi AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emmi. The board's role is to monitor Emmi AG's management team and ensure that shareholders' interests are well served. Emmi AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emmi AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Knecke, Chief Management | ||
| Jonas Leu, Ex Management | ||
| Othmar Dubach, Member Switzerland | ||
| Robin Barraclough, Ex Management | ||
| Ricarda Demarmels, CFO Management | ||
| Urs HSG, Chairman CEO | ||
| Thomas Morf, Chief Management | ||
| Natalie Redi, Chief Management | ||
| Marc Heim, Ex CEO | ||
| Markus Abt, Head Communications |
Emmi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Emmi AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0663 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.94 B | |||
| Shares Outstanding | 5.35 M | |||
| Shares Owned By Insiders | 60.64 % | |||
| Shares Owned By Institutions | 15.53 % | |||
| Price To Earning | 19.03 X | |||
| Price To Book | 4.12 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Emmi Stock Analysis
When running Emmi AG's price analysis, check to measure Emmi AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emmi AG is operating at the current time. Most of Emmi AG's value examination focuses on studying past and present price action to predict the probability of Emmi AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emmi AG's price. Additionally, you may evaluate how the addition of Emmi AG to your portfolios can decrease your overall portfolio volatility.